Location: Home
  • search
  • go
  • Relate News
  • 3/12/2026Almirall Expands China Presence, Seeks More Dermatology Partnerships
  • 2/28/2026bioMérieux CEO Flags "Negative Healthcare Market Evolution" in China
  • 2/26/2026China Pharmaceutical Market Projected to Reach US$573B by 2033
  • 2/25/2026Global Pharma Giants Rush to License Chinese Weight-Loss Drugs, Eye Ob...
  • 2/24/2026CDE Issues Guidelines on Benefit-Risk Assessment Using Multi-Regional ...
  • 2/21/2026Leo Pharma Eyes China Comeback After Decade-Long Launch Drought
  • 2/16/2026Long-Acting Obesity Drugs Drive Record January Licensing Boom for Chin...
  • 2/14/2026Recordati to Withdraw from China After Rare Disease Portfolio Underper...
  • 2/12/2026Today's China Crucible: What It Means for Pharma (PharmExec)
  • 2/10/2026AstraZeneca's China Business Hits New Heights as Record Revenue Boosts...
  • 2/5/2026AmCham China Hosts US FDA Delegation to Strengthen Regulatory Dialogue
  • 2/5/2026Global Pharma in 2025: China Remains a Key Market Amid Rising Competit...
  • 2/3/2026China and USFDA Officials Pledge to Deepen Regulatory Cooperation at B...
  • 1/30/2026Roche's 2025 Results Highlight Strong China Growth amid Global Expansi...
  • 1/29/2026AstraZeneca Deepens China Commitment With $15B Investment
  • 1/16/2026AmCham China Survey Shows Resilience and Improving Performance Among U...
  • 1/13/2026China's 2025 Foreign Investment Catalogue Unlocks Full-Chain Support f...
  • 1/12/2026China's Innovative Drug Licensing Deals Reach Record Peak in 2025
  • 1/12/2026China's Biopharma Sector Sets New Record for International Licensing D...
  • 1/12/2026Recordati Folds Operations in China
  • 1/8/2026China Convenes National Health Work Conference to Outline 2026 Priorit...
  • 1/8/2026China Outlines 2026 Drug Regulatory Priorities with Focus on Safety, I...
  • 12/30/2025Ultra-Low Flu Shot Prices Highlight Intensifying Pressure on China's V...
  • 12/18/2025CSL Elevates China to Core Global Strategic Market
  • 12/17/2025GE HealthCare Opens New R&D Center in Tianjin
  • 12/9/2025Global Pharmas Turn to China Not Just for Assets, but for a New R&D Pl...
  • 12/2/2025China Used to Be a Cash Cow for Western Companies. Now It's a Test Lab...
  • 12/1/2025MNC's County-Level Ambitions Falter as Strategies Shift From Heavy Inv...
  • 11/21/2025China's Biopharma Innovation Surges — McKinsey Lays Out Both Opportun...
  • 11/20/2025China's Pharmaceutical Market Enters a New Consumer-Driven Era
  • Page:1/41 Total number of articles:1225: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group